Aelea Commodities Ltd Q1 FY27 Earnings Analysis

Published 31 May 2026 | Agricultural Food & other Products | Market Cap: ₹301 Cr

Price

161

Market Cap

₹301 Cr

P/E Ratio

49.4

Revenue Rank

Rank 2

Margin Rank

Rank 3

Earnings Summary

- FY26 capacity was fully utilized; FY27 expected to deliver good growth primarily via better quality RCN processing leading to improved kernel recovery rates and operational efficiency (Page 19). - The company aims to continue a similar growth trajectory in FY27 as seen in FY26, with significant increases in both top line and bottom line expected due to deeper integration into the value chain. - Management refrains from providing specific numeric guidance for FY27 and FY28 but indicates confidence in maintaining strong growth rates. - EBITDA margins are maintained around 10-11%, consistent with industry standards. - Investment in CNSL (Cashew Nut Shell Liquid) extraction facilities is expected to enhance bottom-line contribution, with up to 10% EBITDA margin on CNSL products. - B2C segment currently represents about 1% of sales, with plans to grow organically over the next 10 years, potentially contributing improved profitability (~13-15% EBITDA margin in B2C). - Earnings Per Share (EPS) for FY26 stood at around Rs.

📊 Revenue & Sales Performance

Rank 2

- FY26 capacity was fully utilized; FY27 expected to deliver good growth primarily via better quality RCN processing leading to improved kernel recovery rates and operational efficiency (Page 19). - Top-line growth in FY27 expected to be at a similar trajectory as FY26, though no precise numbers provided due to regulatory constraints (Page 17). - Incremental growth will come from existing distributors, institutional clients, and deeper value chain integration (Pages 14, 16). - Direct procurement from Africa at sea-transit level targeted in FY27 to improve sourcing consistency (Page 19). - Expansion into B2C segment is in early stages, currently only 1% of sales, with plans for gradual organic and profitable growth over 10 years (Page 17). - Capacity enhancements with CNSL phase two underway and phase three planned, contributing more to bottom-line than top-line in the medium term (Pages 14, 12). - Finance costs expected to rise with deeper value chain penetration supporting growth (Page 9).

📈 Profitability & Margins

Rank 3

- The company aims to continue a similar growth trajectory in FY27 as seen in FY26, with significant increases in both top line and bottom line expected due to deeper integration into the value chain. - Management refrains from providing specific numeric guidance for FY27 and FY28 but indicates confidence in maintaining strong growth rates. - EBITDA margins are maintained around 10-11%, consistent with industry standards. - Investment in CNSL (Cashew Nut Shell Liquid) extraction facilities is expected to enhance bottom-line contribution, with up to 10% EBITDA margin on CNSL products. - B2C segment currently represents about 1% of sales, with plans to grow organically over the next 10 years, potentially contributing improved profitability (~13-15% EBITDA margin in B2C). - Earnings Per Share (EPS) for FY26 stood at around Rs. 10.46, with expectations for continued improvement aligned with revenue and profit growth.

🏗️ Capital Expenditure Plans

Yes

- Phase two CNSL (Cashew Nut Shell Liquid) extraction facility capex is already committed and underway with expected commissioning around H2 FY27. - Phase three capex for CNSL is planned for the later part of FY27 after stabilizing phase two operations. - Ground-mounted solar installation execution is pending due to government policy approvals, while rooftop solar is completed. - Future capex will focus on scaling operations, renewable energy integration, and expansion into value-added products like biochar, activated carbon, biofuels. - Strategic focus includes deepening value chain to improve margins and increase direct sourcing (~60-65% direct sourcing in FY27 expected). - Longer-term 10-year strategy involves growth in food, feed, fuel, and fertility segments with sustainability at the core. - Incremental capital investments will support capacity expansion from 40 to 140 metric tonnes per day.

💰 Fundraising & Capital Structure

No information

- The company has not explicitly mentioned any immediate plans for new fundraising through debt or equity. - Finance costs have increased significantly due to deeper value chain involvement, leading to higher short-term borrowings. - Phase two Capex is underway and mostly committed, with a small amount pending. - Phase three Capex will happen after stabilization of phase two, planned for the later part of the year. - Going forward, finance costs may increase as the company deepens its value chain. - No clear mention of fresh equity fundraising; focus appears to be on operational growth and Capex via existing or planned funding. - Guidance for FY27 and FY28 indicates continued growth but no explicit fundraising plans disclosed.

📋 Order Book & Pipeline

No information

The transcript does not explicitly mention current or expected order book or pending orders for Aelea Commodities Limited. However, relevant insights include: - Capacity utilization is high, around 94-95%, indicating strong ongoing demand. - The company is focusing on deepening its value chain and increasing volumes, especially in cashew processing. - Growth is expected to continue in FY27 at a similar trajectory to FY26. - Expansion projects like CNSL Phase 2 are underway, with Phase 3 planned after stabilization, supporting future volume increases. - The company emphasizes consistency in supply and is actively sourcing better quality raw materials, including direct sourcing from Africa. - Institutional client onboarding and distribution network expansion are part of growth strategies, implying a strong potential order pipeline. No direct figures for order backlog or pending orders are disclosed in the call transcript.

Key Metrics

Revenue

Rank 2

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

No information

Frequently Asked Questions

What were Aelea Commodities Ltd Q1 FY27 results?

- FY26 capacity was fully utilized; FY27 expected to deliver good growth primarily via better quality RCN processing leading to improved kernel recovery rates and operational efficiency (Page 19). - The company aims to continue a similar growth trajectory in FY27 as seen in FY26, with significant increases in both top line and bottom line expected due to deeper integration into the value chain. - Management refrains from providing specific numeric guidance for FY27 and FY28 but indicates confidence in maintaining strong growth rates. - EBITDA margins are maintained around 10-11%, consistent with industry standards. - Investment in CNSL (Cashew Nut Shell Liquid) extraction facilities is expected to enhance bottom-line contribution, with up to 10% EBITDA margin on CNSL products. - B2C segment currently represents about 1% of sales, with plans to grow organically over the next 10 years, potentially contributing improved profitability (~13-15% EBITDA margin in B2C). - Earnings Per Share (EPS) for FY26 stood at around Rs.

What is Aelea Commodities Ltd share price analysis?

Aelea Commodities Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 49.4 with a market cap of ₹301. Investors should review the full earnings analysis for detailed insights.

Is Aelea Commodities Ltd planning capital expenditure?

- Phase two CNSL (Cashew Nut Shell Liquid) extraction facility capex is already committed and underway with expected commissioning around H2 FY27.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.